PDPM Payment Calculator – FY2021 PPS PDPM Rates (Urban) - Montero Therapy and MDS Services
NAFLD Fibrosis Score Calculator
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Summary of non-invasive scoring systems based on biochemical markers in... | Download Table
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect
NAFLD fibrosis score + FIB4 | Infamedic
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
An overview of the genetics, mechanisms and management of NAFLD and ALD | RCP Journals
Non Alcoholic Fatty Liver Disease NAFLD - ppt download
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome | Article
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects | Scientific Reports
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
Life | Free Full-Text | Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect
The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease | PLOS ONE
